Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kallikrein-related peptidase 7 (KLK7), also known as stratum corneum chymotryptic enzyme (SCCE), is a secreted serine protease predominantly expressed in the epidermis. It plays a crucial role in skin desquamation by catalyzing the degradation of intercellular cohesive structures, such as corneodesmosomes, in the stratum corneum. Under physiological conditions, this activity facilitates the continuous shedding of outer epidermal cells. However, pathological overexpression or dysregulation of KLK7 is a major driver of skin barrier disruption, chronic itch, and inflammation in diseases such as atopic dermatitis, Netherton syndrome, and psoriasis. Beyond dermatology, elevated KLK7 levels are associated with tumor progression, invasion, and metastasis in several malignancies, including ovarian, pancreatic, and breast cancers. Therapeutic strategies targeting KLK7 primarily focus on monoclonal and bispecific antibodies (such as TRIV-509 and TRIV-573) that inhibit its enzymatic activity, thereby restoring epidermal barrier integrity and alleviating inflammatory symptoms.
Inhibition of Kallikrein-7 enzymatic activity (often dual inhibition with Kallikrein-5) to prevent degradation of corneodesmosomes, restore skin barrier integrity, and reduce inflammation and itch.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kallikrein-related peptidase 7 (KLK7) (KLK7).